Vibhudutta Awasthi
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (5)
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Metabolic (dysfunction)‐associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease, is a growing global health concern with no approved pharmacological treatments. At the same time, there are no standard methods to definitively screen for the presence of MASLD because of its progressive nature and symptomatic commonality with other disorders. Recent advances in molecular understanding of MASLD pathophysiology have intensified research on development of new drug molecules, repurposing of existing drugs approved for other indications, and an educated use of dietary supplements for its treatment and prophylaxis. This review focused on depicting the latest advancements in MASLD research related to small molecule development for prophylaxis or treatment and diagnosis, with emphasis on mechanistic basis at the molecular level.
Year:
2024
Collaborators (6)
Venkateswararao Eeda
Assistant Professor
University of Oklahoma Health Sciences Center
Priya Balasubramanian
Assistant Professor
University of Oklahoma Health Sciences Center
Madhan Subramanian
Associate Professor
Oklahoma State University
Priyabrata Mukherjee
University of Oklahoma Health Sciences Center
Atul Pranay
Associate Staff Scientist
Oklahoma Medical Research Foundation
Kenneth Humphries
Professor
Oklahoma Medical Research Foundation
Make your next move.
Prepare your application
Review drafts before you send them.